Trinity Biotech (TRIB) announced the appointment of Paul Tivnan to its Board of Directors as a Non-Executive Director. Tivnan currently serves as Chief Financial Officer of Deriva Energy
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Receives Approval for Offshore Manufacturing of HIV Test
- Trinity granted approval for offshore manufacturing of TrinScreen HIV test
- Trinity Biotech Gains Approval for PreClara™ Preeclampsia Testing Service
- Trinity Biotech receives approval from NYSDOH to provide PreClara Ratio
- Trinity Biotech Announces Breakthrough in CGM Technology